about
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersWnt Signaling in Renal Cell CarcinomaControl of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in CancerThe mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapesLack of evidence of the interaction of the Aβ peptide with the Wnt signaling cascade in Drosophila models of Alzheimer's diseaseE7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling.MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.Targeting the WNT Signaling Pathway in Cancer Therapeutics.Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical modelForced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors.Frizzled gene expression and negative regulation of canonical WNT-β-catenin signaling in mouse F9 teratocarcinoma cells.6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.Multitarget Drugs: an Epigenetic Epiphany.Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration.Clonal cooperativity in heterogenous cancers.Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.Nano Let‑7b sensitization of eliminating esophageal cancer stem‑like cells is dependent on blockade of Wnt activation of symmetric division.High-throughput targeted screening in triple-negative breast cancer cells identifies Wnt-inhibiting activities in Pacific brittle stars.1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/β-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-MWhole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation.Hilbert-Schmidt and Sobol sensitivity indices for static and time series Wnt signaling measurements in colorectal cancer - part A.Transcriptome Analysis of Gene Expression Provides New Insights into the Effect of Mild Therapeutic Hypothermia on Primary Human Cortical Astrocytes Cultured under Hypoxia.miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells.The crystal structure of full-length Sizzled from Xenopus laevis yields insights into Wnt-antagonistic function of secreted Frizzled-related proteins.Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy.β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.Wnt Signaling in Cardiac Remodeling and Heart Failure.Application of Synthetic Tumor-Specific Promoters Responsive to the Tumor Microenvironment.Dramatic dysbalancing of the Wnt pathway in breast cancers.Targeting the Metastatic Bone Microenvironment by MicroRNAs.Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genesβcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
P2860
Q26739665-02A36AFB-0B72-4366-951B-F162CC67AD11Q26744312-67BCBDE8-6AD9-4AB3-BEC3-315CD8BC7872Q26747432-C35042C2-BE32-472F-ACB4-230020D1F471Q26799993-E2E1B000-FA00-4222-A75C-609A96AC4FF1Q34515555-9E31CBAF-7765-49A6-BABA-28E1911482D9Q36562360-614E1A98-E9DA-47FE-BA4C-F08771C254FFQ36969218-B560E257-FCC1-425F-BB0D-C04C6A36A950Q37694746-9CB4193A-62ED-4B39-9F56-711DEA1B9F8BQ38455097-C1F088C8-259F-438D-9EEF-13631C3B9CF1Q38573776-32C972CC-DBF7-4BBA-8DF1-5E31EB9B42E5Q38678857-3A4B132C-8726-4A66-A929-267137FA7523Q38705028-410D8AA4-3FD4-4FF8-813E-95A570677503Q38717343-D0263903-0BAC-410B-9D72-4522FACBE532Q38719143-7C233D99-D178-41B5-9291-E31286275DAFQ38739347-6CDB6B1D-0039-45AC-AE0B-AF8A29D150E5Q38748855-912AB2BB-0A95-4E9E-BA70-3788362851F3Q38874087-E6321D95-0258-42FD-8143-201636AF6139Q38943125-E97EB648-C44A-4633-91B7-0D699437D6B3Q39433833-1006778E-3AB5-4818-A203-3F5C9FF1538CQ41138932-0E381A04-AEAF-4FCA-BFB9-74433F96AAACQ41389518-C9C93123-8FDB-47A8-9723-B414EAD64557Q41696798-5DFB8FB9-C97D-4E45-9E0E-E34277335091Q46030038-143EDEE7-5395-45A3-B402-FBDFEA971558Q47103031-9584327D-CC18-4F64-8596-6A67E9D5B70BQ47141185-A5EE383F-B561-4BF4-965B-139521CB0549Q47222239-EEA829EF-E486-475F-A004-255158061526Q47757966-32FBEF43-47EF-4D01-BE74-960791425EF8Q47953035-AAB9F13F-0B53-45C4-B60B-BD19ECDD205AQ48259534-E68ECE29-D0CA-422E-A511-9783A37DE3EEQ49243252-BCB530A4-D7C8-425F-9044-456CBCA4011BQ49547317-4CFF553D-D75C-41F3-81C1-F1A83DA05EFDQ50138615-1783F7CF-61EC-4B94-87C0-986BC5749971Q52815224-41E836FB-91CB-4329-84F1-525F63C1DB00Q54366680-1A7CCEE1-D164-47B0-87EB-213221750022Q54943418-1E074477-E0F0-4722-8537-FFC0D047F053Q55092271-09195A9E-F8F2-4880-8F18-F68E250EA81BQ58548120-3115FA7D-6BF4-46ED-97A2-906785C4E6F7Q58613626-30BBE4FD-3F00-43FB-94E7-2C66405714EB
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting the Wnt pathways for therapies
@ast
Targeting the Wnt pathways for therapies
@en
Targeting the Wnt pathways for therapies
@nl
type
label
Targeting the Wnt pathways for therapies
@ast
Targeting the Wnt pathways for therapies
@en
Targeting the Wnt pathways for therapies
@nl
prefLabel
Targeting the Wnt pathways for therapies
@ast
Targeting the Wnt pathways for therapies
@en
Targeting the Wnt pathways for therapies
@nl
P2093
P2860
P3181
P356
P1476
Targeting the Wnt pathways for therapies
@en
P2093
Artem Blagodatski
Dmitry Poteryaev
Vladimir L Katanaev
P2860
P2888
P3181
P356
10.1186/2052-8426-2-28
P407
P577
2014-01-01T00:00:00Z